THE EFFECT OF IMATINIB MESYLATE IN NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE, CHRONIC-PHASE MYELOID LEUKEMIA IN SUB-SAHARAN AFRICAN PATIENTS: THE EXPERIENCE OF CÔTE D’IVOIRE

Objective:  Imatinib mesylate has shown encouraging activity in chronic myelogenous leukemia (CML). However, to the best of our knowledge, there are few data regarding imatinib efficacy and response monitoring in Sub-Saharan African patients.  Our objective was to assess response to imatinib in Côte...

Full description

Bibliographic Details

Published in:	Mediterranean Journal of Hematology and Infectious Diseases
Main Authors:	GUSTAVE Kouassi KOFFI, Alain Attia, Emeraude N'dahtz, Clotaire Nanho, Romance Dissieka, Aissata Tolo, Paul Kouehion, Mozard Konan, Boidy Kouakou, N'dogomo Meité, Romeo Ayemou, Yassongui Sekongo, Norbert Tea, Ibrahima Sanogo
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-08-01
Subjects:	leukemia Imatinib Mesylate Chronic Myeloid Leukemia Sub-Saharan African patient survival.
Online Access:	https://mjhid.org/index.php/mjhid/article/view/1805